Compare TVTX & AUGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TVTX | AUGO |
|---|---|---|
| Founded | N/A | 1946 |
| Country | United States | United States |
| Employees | N/A | 1462 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.8B |
| IPO Year | 2013 | N/A |
| Metric | TVTX | AUGO |
|---|---|---|
| Price | $56.17 | $54.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | $40.62 | ★ $67.60 |
| AVG Volume (30 Days) | ★ 1.8M | 1.0M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.97% |
| EPS Growth | ★ 92.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $44.76 | $91.05 |
| Revenue Next Year | $35.51 | $17.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.03 | $23.55 |
| 52 Week High | $60.10 | $110.32 |
| Indicator | TVTX | AUGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.14 | 42.02 |
| Support Level | $54.87 | $50.75 |
| Resistance Level | $59.89 | $54.30 |
| Average True Range (ATR) | 2.37 | 3.74 |
| MACD | -0.66 | -0.63 |
| Stochastic Oscillator | 46.64 | 28.78 |
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.